Icahn School of Medicine at Mount Sinai clinical trial pipeline

23 trials changed in the last 30 days: 4 stopped, 11 with notable changes, 8 with minor changes only.

1. Stopped

   Abbott i-STAT TBI Biomarker Test

   Trial terminated

   Sponsor's reason: Study was terminated early due to recruitment limitations and available funding for continued recruitment and follow up

   Also in this update: Final enrollment: 42 participants — 9% of the 450 planned; Primary completion date changed from estimate of Sep 2025 to Mar 30, 2026

   Icahn School of Medicine at Mount Sinai·Not applicable· NCT06766435· Registry history of NCT06766435 on ClinicalTrials.gov (opens the registry)

   Updated Oct 15, 2026

2. Stopped

   DECORUM · Delivering Empowering Conversations About Obstetric…DECORUM · Delivering Empowering Conversations About Obstetric Regional Anesthesia for Underserved Minorities

   Trial terminated

   Sponsor's reason: low recruitment lack of support

   Also in this update: Primary completion date changed from estimate of May 2026 to Dec 3, 2024

   Icahn School of Medicine at Mount Sinai·Not applicable· NCT05260242· Registry history of NCT05260242 on ClinicalTrials.gov (opens the registry)

   Updated Oct 13, 2026

3. Stopped

   Behavioral and Cognitive Predictors of Persistent Pain and Opioid…Behavioral and Cognitive Predictors of Persistent Pain and Opioid Misuse in Chronic Pain

   Trial terminated

   Sponsor's reason: PI leaving institution

   Also in this update: Primary completion date changed from estimate of Dec 2025 to Aug 31, 2026

   Icahn School of Medicine at Mount Sinai·Not specified· NCT06288282· Registry history of NCT06288282 on ClinicalTrials.gov (opens the registry)

   Updated Oct 13, 2026

4. Stopped

   Neurocognitive and Genomic Predictors of Persistent Pain and Opioid…Neurocognitive and Genomic Predictors of Persistent Pain and Opioid Misuse After Spine Surgery

   Trial terminated

   Sponsor's reason: PI leaving Institution

   Also in this update: Primary completion date changed from estimate of Jul 2026 to Aug 31, 2026

   Icahn School of Medicine at Mount Sinai·Not specified· NCT06288256· Registry history of NCT06288256 on ClinicalTrials.gov (opens the registry)

   Updated Oct 13, 2026

5. Notable

   TIER-PC · Tier - Palliative Care · Advanced Heart Failure or…TIER-PC · Tier - Palliative Care · Advanced Heart Failure or Cancer

   Primary and study completion pushed from Aug 19, 2026 to Sep 1, 2030

   Icahn School of Medicine at Mount Sinai·Not applicable· NCT06228209· Registry history of NCT06228209 on ClinicalTrials.gov (opens the registry)

   Updated Oct 13, 2026

6. Notable

   ACCESS · Enhancing Access to Supportive Services for Women of…ACCESS · Enhancing Access to Supportive Services for Women of Color With Metastatic Breast Cancer

   Primary completion pushed from Jul 31, 2026 to Sep 1, 2027

   Also in this update: Study completion pushed from Nov 30, 2026 to Sep 1, 2027

   Icahn School of Medicine at Mount Sinai·Not applicable· NCT06405828· Registry history of NCT06405828 on ClinicalTrials.gov (opens the registry)

   Updated Oct 13, 2026

7. Notable

   Topical 0.5% Timolol Solution for Healing Lower Extremity Wounds

   Primary completion pushed from Apr 1, 2026 to Jan 31, 2027

   Also in this update: Study completion pushed from Apr 1, 2026 to Mar 1, 2027

   Icahn School of Medicine at Mount Sinai·Phase 1· NCT06941467· Registry history of NCT06941467 on ClinicalTrials.gov (opens the registry)

   Updated Oct 9, 2026

8. Notable

   Vancomycin Study in Multiple Sclerosis (MS)

   Primary completion pushed from Mar 2026 to Jun 2028

   Also in this update: Study completion pushed from Sep 2026 to Dec 2028

   Icahn School of Medicine at Mount Sinai·Phase 1· NCT05539729· Registry history of NCT05539729 on ClinicalTrials.gov (opens the registry)

   Updated Sep 28, 2026

9. Notable

   Neurosteer Bedside Monitoring System

   Primary and study completion pushed from Jul 2026 to Mar 2028

   Icahn School of Medicine at Mount Sinai·Not applicable· NCT06718764· Registry history of NCT06718764 on ClinicalTrials.gov (opens the registry)

   Updated Sep 28, 2026

10. Notable

    Skin Pigment/Pulse Oximeter in Congenital Heart Disease (CHD)

    Primary and study completion pushed from Jul 2026 to Aug 31, 2027

    Also in this update: Enrollment reduced: 92 → 24 participants

    Icahn School of Medicine at Mount Sinai·Not specified· NCT06575270· Registry history of NCT06575270 on ClinicalTrials.gov (opens the registry)

    Updated Sep 25, 2026

11. Notable

    Improving Outcomes for Older Adults Undergoing Radiation Therapy

    Primary completion pushed from Oct 31, 2025 to Dec 31, 2028

    Also in this update: Study completion pushed from Jun 30, 2026 to Dec 31, 2028

    Icahn School of Medicine at Mount Sinai·Not specified· NCT05721053· Registry history of NCT05721053 on ClinicalTrials.gov (opens the registry)

    Updated Sep 24, 2026

12. Notable

    RT-CA · Mind-body Resilience Program for Cardiac Arrest Survivors…RT-CA · Mind-body Resilience Program for Cardiac Arrest Survivors and Their Caregivers: Recovering Together After Cardiac Arrest

    Sponsor changed: Massachusetts General Hospital to Icahn School of Medicine at Mount Sinai

    Icahn School of Medicine at Mount Sinai·Not applicable· NCT07143357· Registry history of NCT07143357 on ClinicalTrials.gov (opens the registry)

    Updated Oct 7, 2026

13. Notable

    Natural History of MADD

    Recruitment opened

    Icahn School of Medicine at Mount Sinai·Not specified· NCT07734090· Registry history of NCT07734090 on ClinicalTrials.gov (opens the registry)

    Updated Sep 16, 2026

14. Notable

    Transcranial Direct Current Stimulation (tDCS) · Substance Use…Transcranial Direct Current Stimulation (tDCS) · Substance Use Disorder

    Enrollment increased: 120 → 240 participants

    Icahn School of Medicine at Mount Sinai·Not applicable· NCT07318480· Registry history of NCT07318480 on ClinicalTrials.gov (opens the registry)

    Updated Oct 13, 2026

15. Notable

    iMALT · Improving Medication Adherence in Adolescents Who Had a…iMALT · Improving Medication Adherence in Adolescents Who Had a Liver Transplant

    Results posted: Sep 30, 2026

    Icahn School of Medicine at Mount Sinai·Not applicable· NCT03691220· Registry history of NCT03691220 on ClinicalTrials.gov (opens the registry)

    Updated Sep 30, 2026

• Stopped: an ongoing trial was terminated, suspended or withdrawn.
• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.